期刊文献+

DNA-EGS1386胞内诱导核酶P抑制人巨细胞病毒UL49基因的表达 被引量:1

DNA-EGS1386 in cells induced RNase P inhibits the expression of human cytomegalovirus UL49 gene
原文传递
导出
摘要 外部引导序列(EGSs)是一类与mRNA靶序列互补并能引导核酶P切割靶mRNA的小分子RNA。本实验构建稳定表达UL49基因的HeLa细胞系,设计合成了针对于人巨细胞病毒(HCMV)UL49基因的12ntDNA性质的EGS1386,通过转染稳定表达UL49基因的细胞系,荧光定量PCR和Western blotting检测细胞内目的基因UL49的表达情况。结果显示在DNA-EGS1386作用下UL49基因的表达量降低了50%,表明DNA-EGS1386可以有效引导人的核酶P切割目标mRNA。因此,DNA-EGS可以发展成为一种新的基因沉默技术和潜在的抗病毒试剂。 External Guide Sequences(EGSs) represents a novel nucleic acid based gene interference approach to modulate gene expression.They are oligonucleotides that consist of a sequence complementary to a target mRNA and recruit intracellular RNase P for specific degradation of the target RNA.DNA-based EGS1386 with a size of 12 nt was chemically synthesized to target the mRNA coding for the UL49 gene of human cytomegalovirus(HCMV).The DNA-based EGS1386 molecule efficiently directed human RNase P to cleave the target mRNA sequence in vitro.A reduction of more than 50% in the levels of UL49 expression was observed in human cells treated with the DNA-based EGS1386 targeted UL49 assayed by fluorescent quantization PCR and Western blotting.This results showed that the DNA-EGS1386 can effectively guide the RNase P cut the target mRNA.Therefore,DNA-EGS can develop into a new gene silencing technology and potential of the anti-viral reagents.
出处 《生物工程学报》 CAS CSCD 北大核心 2009年第11期1690-1696,共7页 Chinese Journal of Biotechnology
基金 国家自然科学基金(Nos.90608024 30370776) 广州市科技攻关项目(No.2006J1-C0111) 广东省科技计划项目(No.2006B35502002) 广东省自然科学基金重点项目(No.36703) 中国博士后科学基金资助项目(No.20080430845)资助~~
关键词 短的EGS 基因沉默 UL49基因 核酶P miniEGSs gene silencing UL49 gene RNase P
  • 相关文献

参考文献1

二级参考文献14

  • 1Lewin AS, Hauswirth WW. Ribozyme gene therapy: Applications for molecular medicine. Trends Mol Med, 2001, 7(5): 221-228.
  • 2Kijima H, lshida H, Ohkawa T, Kashani-Sabet M, Scanlon KJ. Therapeutic applications of ribozymes. Pharmacol Ther, 1995, 68(2): 247-267.
  • 3Raj SML, Liu FY. Engineering of RNase P ribozyme for gene-targeting applications. Gene, 2003, 313(2003): 59-69.
  • 4Trang P, Hsu AW, Liu FY. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate. Nucleic Acids Res, 1999, 27(23): 4590-4597.
  • 5Kilani AE Trang P, Jo S, Hsu A, Kim J, Nepomuceno E, Liou K et al.RNase Pribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. J Biol Chem, 2000, 275(14): 10611-10622.
  • 6Trang P, Lee M, Nepomuceno E, Kim J, Zhu H, Liu FY. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.Proc Natl Acad Sci USA, 2000, 97(1 l): 5812-5817.
  • 7Baldanti F, Lurain N, Gerna G. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Hum Immunol, 2004, 65(5):403-409.
  • 8Trang P, Kim K, Liu F. Developing RNase P ribozymes for gene-targeting and antiviral therapy. Cell Microbiol, 2004, 6(6): 499-508.
  • 9Zou J, Gong ZX. lnhibtion of replication of goose paramyxovirus SF02 by hammerhead ribozyme targeting to the SF02 F mRNA in chicken embryo fibroblasts. Acta Biochim Biophys Sin, 2003, 35(9): 801-805.
  • 10Zheng WC, Qi GR. tRNA-embedded hammerhead ribozymes mediate destruction of HBV (subtype adr) in vitro. Acta Biochim Biophys Sin,1998, 30(5): 432-438.

共引文献3

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部